Jenny Lin

Taipei, Taiwan

Upcoming update to the Taiwan FDA Medical Devices Act

By Jenny Lin | 2 November 2020
Taiwan has one of the most enviable healthcare systems in the world - it boasts the number one ranking among 93 countries two years in a row from mid-2018 and...
shutterstock_572893948

What you need to know about disinfectants in Australia

By Jenny Lin | 7 August 2020
In May 2020, we looked at hand sanitisers and TGA’s exemption on certain formations in response to the COVID-19 emergency. As we are seeing an increasing number of corporations receiving...
Transition

Make your transition from MDD to MDR – White Paper

By Jenny Lin | 30 August 2019
With less than one year remaining for the transition to the Medical Device Regulation (MDR), this white paper takes a look at the key areas to be addressed for manufacturers...

Search

Recent Posts

DOC’s will need to be submitted for new Class I IVD ARTG registrations

Nov 26, 2020

Formulated ingredients and premixes: Keeping the IP of a PI

Nov 24, 2020

TGA guidance for SaMD Regulatory “Carve Out”

Nov 19, 2020

Upcoming update to the Taiwan FDA Medical Devices Act

Nov 2, 2020

TGA deploys Post Market Review Compliance Dashboard

Oct 29, 2020

TGA Issues guidance for sponsors with lapsing Conformity Assessment Certificates

Oct 19, 2020

Categories

Categories

Archives

Archives

Archives

Tags

510(k) ARTG Australia Biocompatibility Brexit CE CE Certificates clinical trials Conformity Assessment coronavirus COVID-19 COVID19 de novo Drug EU Europe FDA guidance IVD IVDD IVDR IVDs MDD MDR MDSAP medical device Medical Device Regulations medical devices Medicine medicines Notified Bodies Pharmaceutical PMA PMDA postmarket private health insurance Reform Registrations regulatory Reimbursement SaMD Software Software as a Medical Device (SaMD) standards TGA